title: Hypoxia-inducible factor-1alpha is an intrinsic marker for hypoxia in cervical cancer xenografts.
abstract: The hypoxia-inducible factor 1 (HIF-1) is known to induce the expression of several proteins linked to the maintenance of oxygen homeostasis, cellular energy metabolism, and tumor progression. Its alpha subunit (HIF-1alpha) is stabilized under hypoxic conditions and, therefore, might represent an intrinsic marker for tissue hypoxia. Here we report on the spatial relationship between HIF-1alpha and the nitroimidazole hypoxia marker EF5 in cervical carcinoma xenografts, and on their spatial relationship to tumor blood vessels. EF5 was administered to mice bearing ME180 and SiHa cervical cancer xenografts. Frozen tumor tissue sections, triple-stained for HIF-1alpha, the endothelial cell marker CD31, and EF5, were imaged using wide-field multiparameter immunofluorescence microscopy. Expression levels of EF5 and HIF-1alpha were similar in ME180 xenografts, but the percentage of tumor area stained with EF5 was significantly smaller than the percentage of HIF-1alpha-positive area in SiHa tumors. In both tumor types the EF5-HIF-1alpha overlap was statistically significant, thus confirming their spatial and temporal colocalization. Spatial distribution analysis of EF5 and HIF-1alpha is consistent with different pO2 value "thresholds" for EF5 binding and HIF-1alpha expression. Summarized, our results indicate that HIF-1alpha is a useful intrinsic marker for hypoxia in cervical carcinoma xenografts.
authors.affiliation: Department of Medical Biophysics, Ontario Cancer Institute/Princess Margaret Hospital, Toronto, Ontario, Canada, M5G 2M9.
authors.forename: V
authors.initials: V
authors.lastname: Vukovic
authors.forename: H K
authors.initials: HK
authors.lastname: Haugland
authors.forename: T
authors.initials: T
authors.lastname: Nicklee
authors.forename: A J
authors.initials: AJ
authors.lastname: Morrison
authors.forename: D W
authors.initials: DW
authors.lastname: Hedley
mesh_terms: D000818:Animals; D014408:Biomarkers, Tumor / Q000096:biosynthesis*; D002294:Carcinoma, Squamous Cell / Q000098:blood supply / Q000378:metabolism*; D015687:Cell Hypoxia / Q000502:physiology; D017341:Etanidazole / Q000031:analogs & derivatives* / Q000378:metabolism; D005260:Female; D006801:Humans; D006845:Hydrocarbons, Fluorinated / Q000378:metabolism; D051379:Mice; D016513:Mice, SCID; D008856:Microscopy, Fluorescence; D009368:Neoplasm Transplantation; D014183:Transplantation, Heterologous; D002583:Uterine Cervical Neoplasms / Q000098:blood supply / Q000378:metabolism*; D005466:Fluorocarbons
chemical_list: D014408:Biomarkers, Tumor; D017341:Etanidazole; D006845:Hydrocarbons, Fluorinated; C096011:2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl)acetamide; D005466:Fluorocarbons